BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37243019)

  • 1. Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines.
    Nappi E; Racca F; Piona A; Messina MR; Ferri S; Lamacchia D; Cataldo G; Costanzo G; Del Moro L; Puggioni F; Canonica GW; Heffler E; Paoletti G
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.
    Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S
    Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotyping of IgE-Mediated Polyethylene Glycol and/or Polysorbate 80 Allergy.
    Ieven T; Coorevits L; Vandebotermet M; Tuyls S; Vanneste H; Santy L; Wets D; Proost P; Frans G; Devolder D; Breynaert C; Bullens DMA; Schrijvers R
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3146-3160. PubMed ID: 37380070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
    Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
    Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital.
    Paoletti G; Racca F; Piona A; Melone G; Merigo M; Puggioni F; Ferri S; Azzolini E; Lagioia M; Lamacchia D; Cataldo G; Cecconi M; Canonica GW; Heffler E
    World Allergy Organ J; 2021 May; 14(5):100541. PubMed ID: 33850601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 and allergy - what have we learned after two and a half years?
    Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T
    Allergol Select; 2023; 7():101-112. PubMed ID: 37056446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract.
    Gaspar A; Moura AL; Cruz C; Borrego LM
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.
    Pignatti P; Ramirez GA; Russo M; Marraccini P; Nannipieri S; Asperti C; Torre FD; Tiri A; Gatti BM; Gurrado A; Meriggi A; Benanti G; Cilona MB; Pigatto P; Burastero SE; Dagna L; Yacoub MR
    Vaccine; 2023 Jul; 41(32):4693-4699. PubMed ID: 37349223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.
    Otani IM; Tsao LR; Tang M
    Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
    Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.
    Montera MC; Giordano A; Asperti C; Aruanno A; Barzaghi CE; Bignardi D; Borrelli P; Bommarito L; Busa M; Calafiore P; Carusi V; Cinquini M; Cortellini G; Cocchi R; D'Auria F; De Caro F; Demonte A; Di Leo E; Di Lizia M; Di Rienzo A; Fumagalli F; Kihlgren P; Lodi Rizzini F; Macchia D; Manzotti G; Marra AM; Mileto P; Mietta S; Montagni M; Nettis E; Nucera E; Peveri S; Pivetta D; Pirisi M; Ramirez GA; Rivolta F; Rizzi A; Savoia A; Pedicini A; Scarpa A; Zambito M; Zisa G; Yacoub MR
    Eur Ann Allergy Clin Immunol; 2024 Jan; 56(1):17-25. PubMed ID: 36927838
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy.
    Khokhar D; O'Shea KM; Akin C; Baldwin JL; Benjamin MR; Ravikumar R; Hosler M; McMorris MS; Sanders GM; Troost JP; Baptist AP; Oberdoerster DT; Kovalszki A
    J Allergy Clin Immunol Glob; 2022 Nov; 1(4):209-216. PubMed ID: 36090592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.
    Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC
    JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.
    Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K
    Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
    Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
    J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic.
    Mortz CG; Kjaer HF; Rasmussen TH; Rasmussen HM; Garvey LH; Bindslev-Jensen C
    Clin Transl Allergy; 2022 Jan; 12(1):e12111. PubMed ID: 35028130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.
    Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA
    Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxanes hypersensitivity is not a risk factor for severe reactions to SARS-CoV-2 vaccines.
    Cortellini G; Raiteri A; Biagioni B; Liberati S; Lippolis D; Cortellini G; Piscaglia F
    Eur Ann Allergy Clin Immunol; 2023 Sep; 55(5):229-234. PubMed ID: 36047485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.